Display options
Cite
Li H, Long Z, Wang T, et al. Stanozolol and Danazol Have Different Effects on Hematopoiesis in the Murine Model of Immune-Mediated Bone Marrow Failure. Front Med (Lausanne). 2021;8:615195doi: 10.3389/fmed.2021.615195.
Li, H., Long, Z., Wang, T., & Han, B. (2021). Stanozolol and Danazol Have Different Effects on Hematopoiesis in the Murine Model of Immune-Mediated Bone Marrow Failure. Frontiers in medicine, 8615195. https://doi.org/10.3389/fmed.2021.615195
Li, Hongmin, et al. "Stanozolol and Danazol Have Different Effects on Hematopoiesis in the Murine Model of Immune-Mediated Bone Marrow Failure." Frontiers in medicine vol. 8 (2021): 615195. doi: https://doi.org/10.3389/fmed.2021.615195
Li H, Long Z, Wang T, Han B. Stanozolol and Danazol Have Different Effects on Hematopoiesis in the Murine Model of Immune-Mediated Bone Marrow Failure. Front Med (Lausanne). 2021 May 28;8:615195. doi: 10.3389/fmed.2021.615195. eCollection 2021. PMID: 34124083; PMCID: PMC8193361.
Copy Download .nbib Format: NLM
Share it on

Front Med (Lausanne). 2021 May 28;8:615195. doi: 10.3389/fmed.2021.615195. eCollection 2021.

Stanozolol and Danazol Have Different Effects on Hematopoiesis in the Murine Model of Immune-Mediated Bone Marrow Failure.

Frontiers in medicine

Hongmin Li, Zhangbiao Long, Tao Wang, Bing Han

Affiliations

  1. Department of Hematology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Science, Beijing, China.
  2. Institute of Basic Medical Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

PMID: 34124083 PMCID: PMC8193361 DOI: 10.3389/fmed.2021.615195

[No abstract available.]

Copyright © 2021 Li, Long, Wang and Han.

Keywords: animal model; aplastic anemia; danazol; hematopoiesis; stanozolol

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Cell Physiol Biochem. 2018;46(1):365-374 - PubMed
  2. Transplant Proc. 2012 May;44(4):1067-9 - PubMed
  3. J Immunol. 2007 Apr 1;178(7):4159-68 - PubMed
  4. Zhonghua Xue Ye Xue Za Zhi. 2016 Nov 14;37(11):946-951 - PubMed
  5. Am J Hematol. 2002 Nov;71(3):166-71 - PubMed
  6. J Cell Commun Signal. 2017 Dec;11(4):357-367 - PubMed
  7. Curr Treat Options Oncol. 2017 Nov 16;18(12):70 - PubMed
  8. Blood. 2017 Mar 16;129(11):1428-1436 - PubMed
  9. Am J Pathol. 2012 Nov;181(5):1504-12 - PubMed
  10. Haematologica. 2018 May;103(5):759-769 - PubMed
  11. Blood. 2002 Aug 15;100(4):1185-91 - PubMed
  12. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Jun;19(3):793-7 - PubMed
  13. Endocrinology. 1946 Dec;39(6):401-13 - PubMed
  14. Blood. 1965 Oct;26(4):411-20 - PubMed
  15. N Engl J Med. 1957 Apr 18;256(16):719-26 - PubMed
  16. Proc Soc Exp Biol Med. 1966 Jun;122(2):402-3 - PubMed
  17. Lancet. 2004 Jul 24-30;364(9431):355-64 - PubMed
  18. Blood. 2004 Sep 15;104(6):1671-8 - PubMed
  19. Expert Rev Hematol. 2015 Aug;8(4):515-26 - PubMed
  20. J Basic Clin Pharm. 2016 Mar;7(2):27-31 - PubMed
  21. Ann Hematol. 2011 May;90(5):523-7 - PubMed
  22. Sci Transl Med. 2017 Dec 20;9(421): - PubMed
  23. Blood. 1995 Jun 1;85(11):3183-90 - PubMed
  24. Haematologica. 2018 May;103(5):747-749 - PubMed
  25. Blood. 1975 May;45(5):665-70 - PubMed
  26. J Gerontol A Biol Sci Med Sci. 2014 Jun;69(6):725-35 - PubMed
  27. Andrology. 2013 Jan;1(1):24-8 - PubMed
  28. Blood. 1954 Oct;9(10):999-1007 - PubMed
  29. PLoS One. 2015 May 13;10(5):e0126925 - PubMed
  30. Hematology. 2018 Sep;23(8):496-500 - PubMed
  31. Blood. 2012 Mar 1;119(9):2033-43 - PubMed
  32. J Immunol Res. 2017;2017:9786972 - PubMed
  33. Blood. 2018 Dec 27;132(26):2730-2743 - PubMed
  34. Clin Lymphoma Myeloma Leuk. 2018 Feb;18(2):e109-e113 - PubMed
  35. Exp Hematol. 2004 Dec;32(12):1163-72 - PubMed
  36. Haematologica. 2017 Oct;102(10):1691-1703 - PubMed

Publication Types